Articles

7 Stocks to Buy With Stacks of Free Cash Flow

Use the Portfolio Grader to find stocks to buy that have plenty of free cash flow and can easily afford to fund dividends or stock buybacks.

What the Latest Controversy Really Means for SAVA Stock

Headlines and controversy notwithstanding, consider SAVA stock to be one of the more promising biotech plays out there.

Intel Stock Could Still Fall to $20 (or Less!)

INTC stock traders had an extreme reaction to Intel's earnings data, but don't let yourself get distracted as the company still has problems.

There’s a Retirement Crisis in America – Here’s How to Avoid It

Inflation has shattered many folks’ retirement plans. Millions of Americans who worked hard all their lives, thinking they were covered, are now facing a retirement crisis… and inflation is only making it worse. And believe me, I know how it feels...and I also know that it’s possible to turn it around. I certainly didn’t come from wealth. But I discovered a unique system that changed everything for me – and for thousands of other investors, too.

Dump These 10 Stocks Immediately

Today, I want to share 10 stocks that my quantitative system recently flagged as immediate sells. Take a look; some of these names might surprise you.

How to Find the Pockets of Growth In a Down Market

It’s easy to think of “the market” as one entity thanks to indexes like the S&P 500, the NASDAQ, or the Wilshire 5000. They distill everything down to a single number. But there are more than 6,000 publicly traded companies just in the U.S. (and more than 58,000 around the world, according to the World Federation of Exchanges), which means there is a lot going on underneath those index numbers every day. Individual stocks are moving up, down and all around.

Consider Lithium Play ALB Stock After its Post-Earnings Slide

If the continued march of the EV revolutions proves wrong pessimistic lithium demand forecasts, low-priced ALB stock will likely experience an expansion of its forward multiple. Together with further earnings growth, this could ultimately mean big returns for investors buying today.

Mind Medicine’s Bad Trip Won’t End Anytime Soon

Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.

Why You Shouldn’t Worry About Fed Chair Powell’s Hawkish Speech

This was a big week for Wall Street, not just because of the slew of earnings reports that were released, but because of the all-important November Federal Open Market Committee (FOMC) statement.

Why SQM Stock Is a Perfect Fit for All Investors

Given its many positives, now may be the perfect time to lock down a long-term position in SQM stock.

This Is No Time to Hit the ‘Buy’ Button With BABA Stock

BABA stock might look like a bargain, but be careful as a third-term Chinese president might not bode well for Alibaba's bottom line.

Bet on the Lithium Boom With Lithium Americas Stock

Although risky, the prospect of going from zero to billions in revenue, as this miner taps into burgeoning lithium demand, makes LAC stock a speculative buy for investors bullish on the trend.

Activist Investors Can’t Save Salesforce Stock

It's fine to learn all about an activist investor's stake in CRM stock, but don't ignore Salesforce's worrisome revenue guidance cut.

Quant Ratings Updated on 113 Stocks

And as I discussed in last Friday’s Market 360, big earnings misses from Alphabet, Amazon and Meta Platforms triggered huge selloffs in the stocks. Apple’s shares were the only ones to rally after the company reported record sales and net income.

Bet on the Long-Term Bull Case With Livent Stock

The market's current doubtfulness has possibly created an ideal long-term entry point for LTHM stock.

Sorry! You Can’t Turn Back the Clock on META Stock.

How is Mark Zuckerberg's big bet on the metaverse working out so far? Judging by the price action of META stock, the answer is: not so great.

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 113 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

7 F-Rated Growth Stocks to Sell in November

It wasn't that long ago that growth stocks were a reliable part of an portfolio. But times have changed and these are growth stocks to sell.

A New Study Makes Cassava Sciences Stock an Interesting Buy

Making progress with what could ultimately be a breakthrough treatment, consider SAVA stock a great speculative buy, whether now, or on further weakness.